Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

Evaluation of an Online, On Demand Multimodal Wellness Program to Reduce Fatigue and Improve Quality of Life in Progressive Multiple Sclerosis.

for
Primary Progressive Multiple Sclerosis (PPMS),
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 45 - 70

Code: NCT07831928

Recruiting

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

for
Multiple Sclerosis, Relapsing-Remitting
Location: Tampa FL, Louisville KY, Chicago IL, Milwaukee WI,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 10 - 17

Code: NCT06408259

Phase 3, Recruiting

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

for
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Location: Foxboro MA
Sponsor: Neurology Center of New England P.C.

Sex: All

Age: 55 - 70+

Code: NCT06681623

Recruiting

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

for
Non-Active Secondary Progressive Multiple Sclerosis
Location: Boston MA
Sponsor: Tiziana Life Sciences LTD

Sex: All

Age: 18 - 70+

Code: NCT06890923

Phase 2, Recruiting

Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

for
Relapsing-Remitting Multiple Sclerosis
Location: Washington DC
Sponsor: Institute for Clinical Research

Sex: All

Age: 20 - 65

Code: NCT00210301

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

for
Multiple Sclerosis, Relapsing-Remitting
Location: Richardson TX
Sponsor: The University of Texas at Dallas

Sex: All

Age: 18 - 65

Code: NCT05958381

Recruiting

The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis

for
Multiple Sclerosis, Relapsing-Remitting
Location: Gaylord MI
Sponsor: Nelson Mandela Metropolitan University

Sex: All

Age: 20 - 60

Code: NCT01453868

Early Phase 1, Recruiting

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

for
Relapse Remitting Multiple Sclerosis
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18 - 55

Code: NCT05705986

Recruiting

Hydroxychloroquine and Indapamide in SPMS

for
Multiple Sclerosis, Secondary Progressive
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 60

Code: NCT05013463

Phase 2, Recruiting

Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis

for
Relapse Remitting Multiple Sclerosis
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18 - 55

Code: NCT04857489

Recruiting

Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis

for
Multiple Sclerosis, Relapsing-Remitting
Location: Champaign IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 18 - 64

Code: NCT04073940

Recruiting

An Examination of Cognitive Fatigue Using Functional Neuroimaging

for
Multiple Sclerosis, Relapsing-Remitting
Location: West Orange NJ
Sponsor: Kessler Foundation

Sex: All

Age: 18 - 64

Code: NCT04885894

Recruiting

Early Versus Delayed Start of Ocrevus Zunovo for Relapsing Multiple Sclerosis

for
Relapse Remitting Multiple Sclerosis
Location: Oklahoma City OK
Sponsor: Oklahoma Medical Research Foundation

Sex: All

Age: 18+

Code: NCT07878923

Recruiting

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

for
Multiple Sclerosis (Relapsing Remitting)
Location: Atlanta GA
Sponsor: Georgia State University

Sex: All

Age: 45 - 70+

Code: NCT06919900

Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for
Relapsing Remitting Multiple Sclerosis
Location: Baltimore MD, Morgantown WV, Atlanta GA, Milwaukee WI,
Sponsor: SetPoint Medical Corporation

Sex: All

Age: 22 - 60

Code: NCT06796504

Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis
Location: Worcester MA, New York NY, Boca Raton FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07299019

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Halifax, Foxborough MA, Wellesley MA, Worchester MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

for
Multiple Sclerosis, Relapsing-Remitting
Location: Detroit MI
Sponsor: Wayne State University

Sex: All

Age: 18 - 60

Code: NCT04458688

Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

for
Post-Acute COVID-19 Syndrome, ME/CFS, Rheumatic Arthritis,
Location: Delafield WI
Sponsor: Brain Inflammation Collaborative

Sex: All

Age: 2+

Code: NCT04806620

Recruiting

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

for
Primary Progressive Multiple Sclerosis, Primary Progressive MS,
Location: Raleigh NC, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: Sundance Biosciences, Inc.

Sex: All

Age: 18 - 70

Code: NCT07840326

Phase 2, Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis